Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY: SYK )

387.11 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
5 Good Reasons it's Time to Buy High-Yield Dividend King 3M
3M settled the ear plug lawsuit, clearing the path forward. The stock offers investors a high yield and value that may be too hard to pass up 
Via MarketBeat
Topics Lawsuit
Exposures Financial Legal
Boston Scientific Stock Gets 81 RS Rating After Profit Pops 56% In Year
Boston Scientific stock rose from a 34.98 low on June 16, 2022, amid the bear market, to an all-time high 54.66 close on June 22 this year. 
Via Investor's Business Daily
Stryker, NextEra Energy And A Stock Down 18% In Past Month: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Josh Brown of Ritholtz Wealth Management said he is sticking with NextEra Energy, Inc. (NYSE: NEE) 
Via Benzinga
$1000 Invested In Stryker 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Is This MedTech Giant a Buy for Dividend Investors?
The company stands out as a titan of the medical devices industry. 
Via The Motley Fool
Where Stryker Stands With Analysts
Via Benzinga
Peering Into Stryker's Recent Short Interest
Via Benzinga
Earnings Scheduled For August 3, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million. 
Via Benzinga
A Preview Of Stryker's Earnings
Via Benzinga
Stryker to participate in the 2023 Wells Fargo Securities Healthcare Conference
From Stryker Corporation
Via GlobeNewswire
Stryker, Wynn Resorts And A Chinese Tech Giant Expanding AI Capabilities: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Stephen Weiss of Short Hills Capital Partners named Alibaba Group Holding Limited (NYSE: BABA) as his 
Via Benzinga
Nikola's Abrupt CEO Transition, Carl Icahn Led Icahn Enterprises Cuts Dividend Payout, FDA Rejects Mesoblast's Cell Therapy For Kids: Today's Top Stories
Wall Street Journal 
Via Benzinga
Stryker Stock Gets A Boost From Annual Guidance Hike On Better Than Expected Q2 Earnings: The Details
Stryker Corporation (NYSE: SYK) reported Q2 sales of $5 billion, up 11.2% Y/Y (+11.9% in constant currency), beating the consen 
Via Benzinga
Looking At Stryker's Recent Unusual Options Activity
Via Benzinga
$1000 Invested In Stryker 10 Years Ago Would Be Worth This Much Today
Via Benzinga
(SYK) - Analyzing Stryker's Short Interest
Via Benzinga
Stryker reports second quarter 2023 operating results
From Stryker Corporation
Via GlobeNewswire
Stryker declares a $0.75 per share quarterly dividend
From Stryker Corporation
Via GlobeNewswire
3 Stocks That Could Help You Retire a Millionaire
These three stocks have proven track records and possess catalysts that can enable them to continue growing. 
Via The Motley Fool
Where Stryker Stands With Analysts
Via Benzinga
Stryker Announces Commercial Launch of Q Guidance System With Cranial Guidance Software
From Stryker
Via Business Wire
Here's How Much $1000 Invested In Stryker 20 Years Ago Would Be Worth Today
Via Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $4,800 Today
Via Benzinga
Bullish Action: Chipotle, Visa, Stryker Break Through Resistance
Chipotle, Visa, and Stryker recently broke out of chart bases, and remain in buy range on strong fundamental growth, institutional buying and analyst upgrades. 
Via MarketBeat
Stryker to announce financial results for its second quarter of fiscal year 2023
From Stryker Corporation
Via GlobeNewswire
Elective Surgeries Are On the Rise: 3 Stocks That Can Benefit From This Trend
These have been some of the hottest healthcare stocks on the markets this year. 
Via The Motley Fool
DexCom Clears Base, Wall Street Eyes Double-Digit Earnings Growth
DexCom's G7 glucose-monitoring solution is driving revenue growth at the company. Analysts expect strong double-digit EPS growth this year and next. 
Via MarketBeat
This Healthcare Stock Is Sending More Cash to Its Shareholders: Should You Buy It?
The medical devices company announced a payout hike earlier this year. 
Via The Motley Fool
2 Healthcare Stocks That Could Help Set You Up for Life
Healthcare is a critically important economic sector. 
Via The Motley Fool
After Another Surge, Stocks Approach Weekend On Six-Day Win Streak On Rate Hopes
(Friday market open) The S&P 500® Index (SPX) is on a six-day winning streak following another surge yesterday amid growing investor optimism that interest rates might be close to peaking.  
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.